Tianjin Gestational Diabetes Prevention Program (TGDPP) (GDM)
Lifestyle and Genetic Factors on Diabetes Risk in Women With GDM After Delivery: Tianjin Gestational Diabetes Prevention Program (TGDPP)
Sponsor: Tianjin Women and Children's Health Center
A NA clinical study on Gestational Diabetes Mellitus (GDM), this trial is ongoing. The trial is conducted by Tianjin Women and Children's Health Center and has accumulated 7 data snapshots since 2009. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status NA
Status: Active Not Recruiting → Unknown Status
-
Jan 2019 — Jan 2021 [monthly]
Active Not Recruiting NA
Status: Unknown Status → Active Not Recruiting
-
Jun 2018 — Jan 2019 [monthly]
Unknown Status NA
▶ Show 2 earlier versions
-
Feb 2018 — Jun 2018 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Jan 2017 — Feb 2018 [monthly]
Recruiting NA
First recorded
Aug 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Tianjin Women and Children's Health Center
For direct contact, visit the study record on ClinicalTrials.gov .